RAS as an ‘Undruggable’ Drug Target
Guest post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Mutant HRAS, KRAS, or NRAS genes have been found in...
Category: Uncategorized
Guest post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Mutant HRAS, KRAS, or NRAS genes have been found in...
June 2022 marked the 10th Annual Cancer Immunotherapy Month spearheaded by the Cancer Research Institute. Immunotherapy is an umbrella...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
For the past three years, cohorts of talented young researchers from around the world have participated in the AACR Annual...
AACR on Campus – Defeating Cancer through Global Education and Training is a global outreach program that will bring...
Guest post by Patrick Tan, MD, PhD From November 1-3, 2021, Singapore will hold its 13th Frontiers in Cancer...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
One year, to the day, after winning the Nobel Prize in Chemistry for her groundbreaking work on the genetic...
On Wednesday, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report. Now in its 11th year, the report details advances in the cancer research...